Download PDF
J Pediatr Intensive Care 2019; 08(04): 238-241
DOI: 10.1055/s-0039-1693032
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Neurogenic Stunned Myocardium in Two Children with Neurological Injury

Laura Díaz Ruiz
1   Department of Pediatrics, Pediatric Intensive Care Unit, Hospital Universitario 12 de Octubre, Madrid, Spain
,
Iria Durán Lorenzo
1   Department of Pediatrics, Pediatric Intensive Care Unit, Hospital Universitario 12 de Octubre, Madrid, Spain
,
Olga Ordoñez Sáez
1   Department of Pediatrics, Pediatric Intensive Care Unit, Hospital Universitario 12 de Octubre, Madrid, Spain
› Author Affiliations Funding None.
Further Information

Publication History

31 December 2018

28 May 2019

Publication Date:
14 July 2019 (online)

    Permissions and Reprints

Abstract

Neurogenic stunned myocardium is described as sudden and reversible cardiac dysfunction induced by an acute neurological event. This phenomenon has not been thoroughly investigated in infants, and is probably underdiagnosed. Here, we report the cases of two infants with neurogenic stunned myocardium in whom the clinical suspicion was relevant, with a brief discussion of this condition.

Keywords

neurogenic stunned myocardium - cardiac dysfunction - physical child abuse
 

  • References

  • 1 Krishnamoorthy V, Mackensen GB, Gibbons EF, Vavilala MS. Cardiac dysfunction after neurologic injury: what do we know and where are we going?. Chest 2016; 149 (05) 1325-1331
    CrossrefPubMedGoogle Scholar
  • 2 Paur H, Wright PT, Sikkel MB. , et al. High levels of circulating epinephrine trigger apical cardiodepression in a β2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation 2012; 126 (06) 697-706
    CrossrefPubMedGoogle Scholar
  • 3 Surikow SY, Raman B, Licari J, Singh K, Nguyen TH, Horowitz JD. Evidence of nitrosative stress within hearts of patients dying of Tako-tsubo cardiomyopathy. Int J Cardiol 2015; 189: 112-114
    CrossrefPubMedGoogle Scholar
  • 4 Murthy SB, Shah S, Rao CP, Bershad EM, Suarez JI. Neurogenic stunned myocardium following acute subarachnoid hemorrhage: pathophysiology and practical considerations. J Intensive Care Med 2015; 30 (06) 318-325
    CrossrefPubMedGoogle Scholar
  • 5 Brevis Nuñez F, Tschiedel E, Felderhoff-Mueser U, Neudorf U, Chapot R, Dohna-Schwake C. Neurogenic stunned myocardium after embolization in two children with vein of Galen aneurysmal malformation. Neuroradiology 2013; 55 (02) 213-216
    CrossrefPubMedGoogle Scholar
  • 6 Drayer M, Geracht J, Madikians A, Harrison R. Neurogenic stunned myocardium: an unusual postoperative complication. Pediatr Crit Care Med 2006; 7 (04) 374-376
    CrossrefPubMedGoogle Scholar
  • 7 Johnson J, Ragheb J, Garg R, Patten W, Sandberg DI, Bhatia S. Neurogenic stunned myocardium after acute hydrocephalus. J Neurosurg Pediatr 2010; 5 (05) 428-433
    CrossrefPubMedGoogle Scholar
  • 8 Kida K, Akashi YJ, Fazio G, Novo S. Takotsubo cardiomyopathy. Curr Pharm Des 2010; 16 (26) 2910-2917
    CrossrefPubMedGoogle Scholar
  • 9 Bybee KA, Prasad A. Stress-related cardiomyopathy syndromes. Circulation 2008; 118 (04) 397-409
    CrossrefPubMedGoogle Scholar
  • 10 Lyon AR, Bossone E, Schneider B. , et al. Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2016; 18 (01) 8-27
    PubMedGoogle Scholar
  • 11 Scally C, Rudd A, Mezincescu A. , et al. Persistent long-term structural, functional, and metabolic changes after stress-induced (Takottsubo) cardiomyopathy. Circulation 2018; 137 (10) 1039-1048
    CrossrefPubMedGoogle Scholar
  • 12 Schwarz K, Ahearn T, Srinivasan J. , et al. Alterations in cardiac deformation, timing of contraction and relaxation, and early myocardial fibrosis accompany the apparent recovery of acute stress-induced (Takotsubo) cardiomyopathy: an end to the concept of transience. J Am Soc Echocardiogr 2017; 30 (08) 745-755
    CrossrefPubMedGoogle Scholar
  • 13 Bulsara KR, McGirt MJ, Liao L. , et al. Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage. J Neurosurg 2003; 98 (03) 524-528
    CrossrefPubMedGoogle Scholar
  • 14 Nguyen TH, Neil CJ, Sverdlov AL. , et al. N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy. Am J Cardiol 2011; 108 (09) 1316-1321
    CrossrefPubMedGoogle Scholar
  • 15 Ono R, Falcão LM. Takotsubo cardiomyopathy systematic review: pathophysiologic process, clinical presentation and diagnostic approach to Takotsubo cardiomyopathy. Int J Cardiol 2016; 209 (209) 196-205
    CrossrefPubMedGoogle Scholar
  • 16 Varvarousi G, Xanthos T, Sarafidou P. , et al. Role of levosimendan in the management of subarachnoid hemorrhage. Am J Emerg Med 2016; 34 (02) 298-306
    CrossrefPubMedGoogle Scholar
  • 17 Busani S, Rinaldi L, Severino C, Cobelli M, Pasetto A, Girardis M. Levosimendan in cardiac failure after subarachnoid hemorrhage. J Trauma 2010; 68 (05) E108-E110
    CrossrefPubMedGoogle Scholar
  • 18 Papanikolaou J, Tsolaki V, Makris D, Zakynthinos E. Early levosimendan administration may improve outcome in patients with subarachnoid hemorrhage complicated by acute heart failure. Int J Cardiol 2014; 176 (03) 1435-1437
    CrossrefPubMedGoogle Scholar
  • 19 Llorens-Soriano P, Carbajosa-Dalmau J, Fernández-Cañadas J. , et al. [Clinical experience with levosimendan in the emergency department of a tertiary care hospital]. Rev Esp Cardiol 2007; 60 (08) 878-882
    CrossrefPubMedGoogle Scholar